Table 3.
Outcome domain | Outcome Secondary (S) Exploratory (E) | Group comparisons | |||||
---|---|---|---|---|---|---|---|
| |||||||
SAU - MHC | SAU - INT | MHC - INT | |||||
|
|
|
|||||
Diff | P-value (98.3%CI) | Diff | P-value (98.3%CI) | Diff | P-value (98.3%CI) | ||
6-month follow-up | |||||||
Symptoms | BAI (S) | 2.16 | 0.0051 a (0.32–4.01) | 1.23 | 0.122 (-0.67–3.13) | -0.97 | 0.199 (-2.79–0.84) |
BDI (S) | 1.37 | 0.112 (-0.7–3.44) | 0.52 | 0.548 (-1.55–2.59) | -0.84 | 0.316 (-2.85–1.17) | |
PSS (S) | 1.83 | 0.0055 a (0.26–3.41) | 0.43 | 0.506 (-1.13–2) | -1.40 | 0.0261 b(-2.91–0.11) | |
KES (E) | 5.24 | 0.0007 a (1.57–8.91) | 3.04 | 0.0445 b(-0.59–6.67) | -2.20 | 0.133 (-5.7–1.31) | |
4DSQ-somatization (E) | 1.28 | 0.0402 b (-0.21–2.77) | 0.97 | 0.136 (-0.59–2.52) | -0.36 | 0.544 (-1.76–1.05) | |
4DSQ-distress (E) | 1.41 | 0.0365 b (-0.21–3.03) | 1.06 | 0.114 (-0.55–2.68) | -0.33 | 0.604 (-1.88–1.21) | |
4DSQ-anxiety (E) | 0.70 | 0.065 (-0.21–1.6) | 0.55 | 0.14 (-0.34–1.43) | -0.17 | 0.64 (-1.03–0.7) | |
4DSQ-depression (E) | 0.14 | 0.527 (-0.38–0.66) | -0.06 | 0.788 (-0.6–0.48) | -0.19 | 0.4 (-0.73–0.35) | |
Functioning | WSAS (S) | 2.11 | 0.0234 b (-0.12–4.33) | 0.99 | 0.28 (-1.2–3.18) | -1.13 | 0.195 (-3.22–0.96) |
Presenteeism | SPS (E) | 0.13 | 0.675 (-0.62–0.89) | 0.12 | 0.682 (-0.6–0.85) | 0.00 | 0.99 (-0.67–0.66) |
Self-efficacy | IPQ (E) | -0.09 | 0.801 (-1–0.81) | -0.31 | 0.409 (-1.21–0.59) | -0.20 | 0.585 (-1.07–0.67) |
GSE (E) | -0.30 | 0.632 (-1.82–1.22) | 0.53 | 0.411 (-1.01–2.07) | 0.83 | 0.187 (-0.68–2.35) | |
RTW-SE (E) | -0.47 | 0.588 (-2.53–1.6) | -0.20 | 0.811 (-2.25–1.84) | 0.30 | 0.713 (-1.67–2.28) | |
Life quality | QoL (E) | -0.10 | 0.94 (-3.24–3.04) | 0.53 | 0.682 (-2.6–3.67) | 0.60 | 0.636 (-2.45–3.65) |
EQ5 (E) | -0.02 | 0.166 (-0.05–0.01) | 0.00 | 0.787 (-0.03–0.03) | 0.01 | 0.246 (-0.02–0.04) | |
Satisfaction | CSQ (E) | -2.68 | <0.0005 a (-4.12–-1.24) | -2.86 | <0.0005 a(-4.29–-1.43) | -0.18 | 0.744 (-1.49–1.14) |
12-month follow-up | |||||||
Symptoms | BAI (E) | 1.32 | 0.084 (-0.51–3.14) | 1.03 | 0.184 (-0.83–2.9) | -0.31 | 0.676 (-2.09–1.47) |
BDI (E) | -0.20 | 0.819 (-2.28–1.88) | -0.49 | 0.563 (-2.53–1.55) | -0.27 | 0.747 (-2.28–1.74) | |
PSS (E) | 0.38 | 0.57 (-1.23–2) | 0.50 | 0.456 (-1.11–2.12) | 0.12 | 0.857 (-1.49–1.73) | |
KES (E) | 3.56 | 0.0233 b(-0.2–7.31) | 2.28 | 0.147 (-1.49–6.04) | -1.27 | 0.412 (-4.98–2.44) | |
4DSQ-somatization (E) | 0.92 | 0.139 (-0.57–2.41) | 0.89 | 0.163 (-0.64–2.42) | -0.07 | 0.911 (-1.48–1.35) | |
4DSQ-distress (E) | 0.45 | 0.503 (-1.17–2.07) | 0.44 | 0.507 (-1.16–2.05) | 0.01 | 0.994 (-1.6–1.61) | |
4DSQ-anxiety (E) | 0.47 | 0.196 (-0.4–1.33) | 0.42 | 0.233 (-0.43–1.27) | -0.05 | 0.874 (-0.88–0.77) | |
4DSQ-depression (E) | -0.31 | 0.144 (-0.83–0.2) | -0.18 | 0.41 (-0.7–0.34) | 0.14 | 0.521 (-0.39–0.68) | |
Functioning | WSAS (E) | 0.05 | 0.955 (-2.18–2.29) | -0.22 | 0.812 (-2.45–2.01) | -0.28 | 0.754 (-2.42–1.86) |
Presenteeism | SPS (E) | 0.03 | 0.932 (-0.9–0.97) | -0.32 | 0.397 (-1.21–0.58) | -0.31 | 0.375 (-1.15–0.53) |
Self-efficacy | IPQ (E) | -0.03 | 0.936 (-0.96–0.9) | -0.22 | 0.578 (-1.19–0.74) | -0.18 | 0.649 (-1.1–0.75) |
GSE (E) | 0.08 | 0.898 (-1.45–1.61) | 0.97 | 0.138 (-0.6–2.54) | 0.90 | 0.161 (-0.64–2.44) | |
RTW-SE (E) | -0.16 | 0.858 (-2.26–1.95) | -0.04 | 0.963 (-2.14–2.06) | 0.16 | 0.857 (-1.9–2.21) | |
Life quality | QoL (E) | 1.28 | 0.327 (-1.85–4.41) | 0.65 | 0.616 (-2.45–3.74) | -0.65 | 0.61 (-3.71–2.41) |
EQ5 (E) | -0.01 | 0.468 (-0.04–0.02) | 0.00 | 0.993 (-0.03–0.03) | 0.01 | 0.452 (-0.02–0.04) |
P≤0.0167.
0.05 ≤P< 0.0167.